Puriblood Medical Co., Ltd.
Puriblood Medical Co., Ltd. engages in the research and development of blood purification-related medical devices in Taiwan. The company offers leukoreduction, cell separation, and P-Tex, an advanced anti-fouling technology, which is composed by bio-inspired molecular formula. It is also involved in animal blood transfusion. Puriblood Medical Co., Ltd. was incorporated in 2015 and is based in Hsi… Read more
Puriblood Medical Co., Ltd. (6847) - Total Assets
Latest total assets as of June 2025: NT$253.71 Million TWD
Based on the latest financial reports, Puriblood Medical Co., Ltd. (6847) holds total assets worth NT$253.71 Million TWD as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Puriblood Medical Co., Ltd. - Total Assets Trend (2019–2024)
This chart illustrates how Puriblood Medical Co., Ltd.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Puriblood Medical Co., Ltd. - Asset Composition Analysis
Current Asset Composition (December 2024)
Puriblood Medical Co., Ltd.'s total assets of NT$253.71 Million consist of 53.3% current assets and 46.7% non-current assets.
| Asset Category | Amount (TWD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 33.4% |
| Accounts Receivable | NT$14.90 Million | 5.8% |
| Inventory | NT$29.97 Million | 11.6% |
| Property, Plant & Equipment | NT$0.00 | 0.0% |
| Intangible Assets | NT$9.68 Million | 3.7% |
| Goodwill | NT$0.00 | 0.0% |
Asset Composition Trend (2019–2024)
This chart illustrates how Puriblood Medical Co., Ltd.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Puriblood Medical Co., Ltd.'s current assets represent 53.3% of total assets in 2024, an increase from 2.4% in 2019.
- Cash Position: Cash and equivalents constituted 33.4% of total assets in 2024, up from 2.0% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, a decrease from 12.0% in 2019.
- Asset Diversification: The largest asset category is inventory at 11.6% of total assets.
Puriblood Medical Co., Ltd. Competitors by Total Assets
Key competitors of Puriblood Medical Co., Ltd. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Revvity Inc.
NYSE:RVTY
|
USA | $12.17 Billion |
|
SMO ClinPlus Co. Ltd.
SHE:301257
|
China | CN¥1.47 Billion |
|
Berry Genomics Co Ltd
SHE:000710
|
China | CN¥2.34 Billion |
|
Malaysian Genomics Resource
KLSE:0155
|
Malaysia | RM20.70 Million |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
Korea | ₩121.79 Billion |
|
GeneMatrix Inc
KQ:109820
|
Korea | ₩28.03 Billion |
|
Genoray Co. Ltd
KQ:122310
|
Korea | ₩125.67 Billion |
|
Green Cross Lab Cell Corporation
KQ:144510
|
Korea | ₩565.79 Billion |
Puriblood Medical Co., Ltd. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Puriblood Medical Co., Ltd. generates 0.43x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Puriblood Medical Co., Ltd. is currently not profitable relative to its asset base.
Puriblood Medical Co., Ltd. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.81 | 4.34 | 3.34 |
| Quick Ratio | 2.09 | 3.33 | 3.10 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | NT$85.87 Million | NT$ 104.57 Million | NT$ 43.38 Million |
Puriblood Medical Co., Ltd. - Advanced Valuation Insights
This section examines the relationship between Puriblood Medical Co., Ltd.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 6.44 |
| Latest Market Cap to Assets Ratio | 0.05 |
| Asset Growth Rate (YoY) | -2.4% |
| Total Assets | NT$259.15 Million |
| Market Capitalization | $13.75 Million USD |
Valuation Analysis
Below Book Valuation: The market values Puriblood Medical Co., Ltd.'s assets below their book value (0.05 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Puriblood Medical Co., Ltd.'s assets decreased by 2.4% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Puriblood Medical Co., Ltd. (2019–2024)
The table below shows the annual total assets of Puriblood Medical Co., Ltd. from 2019 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | NT$259.15 Million | -2.40% |
| 2023-12-31 | NT$265.51 Million | -17.16% |
| 2022-12-31 | NT$320.50 Million | +20.67% |
| 2021-12-31 | NT$265.60 Million | +35.44% |
| 2020-12-31 | NT$196.11 Million | +129.45% |
| 2019-12-31 | NT$85.47 Million | -- |